Blue Water Vaccines, Inc. (BWV) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Cincinnati, OH, United States. El CEO actual es Neil J. Campbell MA, MBA.
BWV tiene fecha de IPO 2022-02-18, 12 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $3.41M.
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
